4 May 2023
LungLife AI, Inc.
(the “Company” or “LungLife”)
Result of Annual General Meeting
LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces that at its Annual General Meeting, held at earlier today, all 10 resolutions put to members were passed on a poll.
The number of votes lodged by proxy for and against each of the resolutions proposed, and the number of votes withheld was as follows:
| Resolution | Votes for | % | Votes against | % | Votes withheld |
| Resolution 1 (Common) TO receive the Annual Report and Accounts of the Company for the year ended 31 December 2022 together with the directors’ and auditor’s reports thereon. | 13,016,289 | 100.00 | 0 | 0.00 | 0 |
| Resolution 2 (Common) TO approve the Directors’ Remuneration Policy. | 9,997,926 | 76.81 | 3,018,363 | 23.19 | 0 |
| Resolution 3 (Common) TO receive the Directors’ Remuneration Report for the year ended 31 December 2022. | 13,016,289 | 100.00 | 0 | 0.00 | 0 |
| Resolution 4 (Common) THAT Roy Davis be, and hereby is, re-elected as a director of the Company to hold office until the conclusion of the next Annual General Meeting of the Company. | 13,016,289 | 100.00 | 0 | 0.00 | 0 |
| Resolution 5 (Common) THAT Paul Pagano be, and hereby is, re-elected as a director of the Company to hold office until the conclusion of the next Annual General Meeting of the Company. | 13,016,289 | 100.00 | 0 | 0.00 | 0 |
| Resolution 6 (Common) THAT David Anderson be, and hereby is, re-elected as a director of the Company to hold office until the conclusion of the next Annual General Meeting of the Company. | 13,016,289
| 100.00 | 0 | 0.00 | 0 |
| Resolution 7 (Common) THAT Andrew Boteler be, and hereby is, re-elected as a director of the Company to hold office until the conclusion of the next Annual General Meeting of the Company. | 13,016,289
| 100.00 | 0 | 0.00 | 0 |
| Resolution 8 (Common) THAT Sara Barrington be, and hereby is, re-elected as a director of the Company to hold office until the conclusion of the next Annual General Meeting of the Company. | 13,016,289
| 100.00 | 0 | 0.00 | 0 |
| Resolution 9 (Common) THAT James McCullough be, and hereby is, re-elected as a director of the Company to hold office until the conclusion of the next Annual General Meeting of the Company. | 13,016,289 | 100.00 | 0 | 0.00 | 0 |
| Resolution 10 (Common) THAT Crowe UK LLP be, and hereby is, reappointed as auditor of the Company to hold office until the conclusion of the next Annual General Meeting of the Company. | 13,016,289 | 100.00 | 0 | 0.00 | 0 |
The Company notes that, whilst Resolution 2 was passed with the required majority, there was a sizable vote against it representing 23% of shareholders who voted. The Company acknowledges these votes and will engage with shareholders to understand further the reasons behind this vote. The Board will provide an update on this engagement and any actions taken will be published within six months of the AGM.
As at 4 May 2023, there were 25,485,982 common shares in issue. Stockholders are entitled to one vote per common share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.
Click HERE for the full announcement.
"*" indicates required fields
LungLife AI licensure/accreditation information posted here.